Table 1.

Novel therapeutic agent indications approved by the US FDA for cardiovascular disease and diabetes between 2005 and 2014

Novel therapeutic agent indication approvals (n = 32)	Number (%)
Orphan statusa
Yes	3 (9)
No	29 (91)
FDA review pathwaya
Priority	6 (19)
Standard	26 (81)
Therapeutic areab
Cardiovascular disease	17 (53)
Diabetes mellitus	15 (47)

FDA Food and Drug Administration

^aFDA designation

^bAs defined by the World Health Organization’s Anatomic Therapeutic Classification system (http://www.whocc.no/atc_ddd_index/), contextualized for clinical relevance